Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis
-
By
-
Bukola Lawal
-
Shuaibu Saidu Musa
-
May Soe Thu
-
Thunnicha Ondee
-
Oranut Chatsirisakul
-
Krit Pongpirul
-
May 21, 2026
-
Clinical Scorecard: Metabolic Alterations After COVID-19 and Their Association with New-Onset Diabetes: A Systematic Review and Meta-Analysis
At a Glance
| Category | Detail |
|---|
| Condition | New-Onset Diabetes Post COVID-19 |
| Key Mechanisms | Impaired glycemic control and increased insulin resistance due to viral effects and systemic inflammation. |
| Target Population | COVID-19 survivors, particularly those with elevated cardiometabolic risk. |
| Care Setting | Post-COVID care and metabolic monitoring. |
Key Highlights
- 41% increased risk of new-onset diabetes among COVID-19 survivors.
- Higher HbA1c and HOMA-IR levels indicate impaired glycemic control.
- Inconsistent findings for fasting blood glucose levels.
- Post-COVID metabolic disturbances may persist beyond acute infection.
- Need for longitudinal follow-up in individuals at risk.
Guideline-Based Recommendations
Diagnosis
- Monitor metabolic parameters in COVID-19 survivors at least three months post-infection.
Management
- Consider metabolic monitoring and interventions for individuals with new-onset diabetes.
Monitoring & Follow-up
- Regular assessment of HbA1c, fasting insulin, and HOMA-IR in post-COVID patients.
Risks
- Increased risk of diabetes and metabolic dysregulation in COVID-19 survivors.
Patient & Prescribing Data
Individuals recovering from COVID-19, especially those with pre-existing metabolic risk factors.
Focus on managing insulin resistance and monitoring glycemic control.
Clinical Best Practices
- Implement routine metabolic assessments for COVID-19 survivors.
- Educate patients on the risk of new-onset diabetes post-COVID.
- Encourage lifestyle modifications to mitigate metabolic risks.
Related Resources & Content
